FDA Inspection
CSL Plasma Inc.CSL Plasma Inc. – FDA Inspection, Apr 9, 2026
Record Details
This FDA Inspection record concerns CSL Plasma Inc., with an inspection on April 9, 2026, issued by the Detroit District Office, covering biologics.
View Company Profile
ID · c85383b1-8208-47a1-b871-486f6d65e75b
Inspection Facts
- Inspection number
- 1311554
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.171Biological product deviation report
- 21 CFR 610.40(h)(2)(ii)Labeling of reactive units, units from deferred donors
- 21 CFR 640.76(c)Source Plasma - Re-labeling
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Plasma Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 20, 2018 | Not classified | Detroit District Office | |
| April 17, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 10, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Plasma Inc.
- FDA Inspection 1057024 - 2018-06-20
- FDA Inspection 832636 - 2013-04-17
- FDA Inspection 710838 - 2011-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.